These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 4978717)

  • 1. [Allopurinol in the prevention and treatment of urate complications in leukemia].
    Aldo C; Roberto M
    Haematologica; 1969; 54(1):17-28. PubMed ID: 4978717
    [No Abstract]   [Full Text] [Related]  

  • 2. [Inhibition of endogenous synthesis of uric acid with allopurinol in patients with gout and urate diathesis].
    Holländer E; Schwarczmann P
    Munch Med Wochenschr; 1969 Aug; 111(32):1623-6. PubMed ID: 5394966
    [No Abstract]   [Full Text] [Related]  

  • 3. [Serum and urine uric acid content in hemoblastoses and gout as well as its modification by allopurinol].
    Helbig W; Findeisen B
    Z Gesamte Inn Med; 1971 Apr; 26(7):233-7. PubMed ID: 5285596
    [No Abstract]   [Full Text] [Related]  

  • 4. [Allopurinol in the treatment of gout. Preliminary report].
    Lignière GC; Cirla E
    Reumatismo; 1968; 20(2):101-3. PubMed ID: 5748155
    [No Abstract]   [Full Text] [Related]  

  • 5. [Allopurinol in the treatment of gout: initial results].
    Serre H; Simon L; Claustre J
    Rev Rhum Mal Osteoartic; 1968 Jun; 35(6):334-44. PubMed ID: 5701049
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapy of gout with allopurinol. (Study of 106 cases)].
    Delbarre F; Auscher C; Amor B; de Géry A
    Sem Hop; 1967 Feb; 43(10):634-43. PubMed ID: 4292982
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of Milurit in the treatment of gout.
    Mituszova L; Erdély E; Bényai B
    Ther Hung; 1973; 21(3-4):111-3. PubMed ID: 4806417
    [No Abstract]   [Full Text] [Related]  

  • 8. Allopurinol in treatment of patients with gout and chronic renal failure.
    Bowie EA; Simmonds HA; North JD
    N Z Med J; 1967 Sep; 66(421):606-11. PubMed ID: 5234549
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trial.
    Schumacher HR; Becker MA; Wortmann RL; Macdonald PA; Hunt B; Streit J; Lademacher C; Joseph-Ridge N
    Arthritis Rheum; 2008 Nov; 59(11):1540-8. PubMed ID: 18975369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effects of allopurinol in gout patients with uric urinary lithiasis or hyperuraturia].
    Delbarre F; Foglierini J; Larrieu F; Frugier JC
    Sem Hop; 1967 Feb; 43(10):652-8. PubMed ID: 4292984
    [No Abstract]   [Full Text] [Related]  

  • 11. [The effect of daily single doses of 300 mg allopurinol on serum uric acid concentration and urate excretion in gouty patients (author's transl)].
    Matzkies F; Berg G
    Dtsch Med Wochenschr; 1974 Nov; 99(48):2464-5. PubMed ID: 4448143
    [No Abstract]   [Full Text] [Related]  

  • 12. [Allopurinol in the treatment of hyperuricemia and chronic gout].
    Benedetti A; Nardini A; Busonera G
    Clin Ter; 1968 Apr; 45(2):141-54. PubMed ID: 5736585
    [No Abstract]   [Full Text] [Related]  

  • 13. [Allopurinol in the treatment of gout].
    Isomäki H; Kemilä S
    Duodecim; 1968; 84(17):975-80. PubMed ID: 5704850
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout.
    Perez-Ruiz F; Calabozo M; Pijoan JI; Herrero-Beites AM; Ruibal A
    Arthritis Rheum; 2002 Aug; 47(4):356-60. PubMed ID: 12209479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Allopurinol in the treatment of gout].
    Sabah D
    Rev Med Chil; 1970; 98(9):622-7. PubMed ID: 5509800
    [No Abstract]   [Full Text] [Related]  

  • 16. [Allopurinol in the treatment of gout].
    Klein G; Griendl W; Kalb R
    Z Rheumaforsch; 1968 Dec; 27(11):455-60. PubMed ID: 5710881
    [No Abstract]   [Full Text] [Related]  

  • 17. [Allopurinol treatment of hyperuricemia].
    Nissen NI; Paikin H
    Nord Med; 1967 Oct; 78(41):1320-4. PubMed ID: 6054472
    [No Abstract]   [Full Text] [Related]  

  • 18. Azapropazone or allopurinol in the treatment of chronic gout and/or hyperuricaemia. A preliminary report.
    Templeton JS
    Br J Clin Pract; 1982 Oct; 36(10):353-8. PubMed ID: 7171423
    [No Abstract]   [Full Text] [Related]  

  • 19. Impact of noncompliance with urate-lowering drug on serum urate and gout-related healthcare costs: administrative claims analysis.
    Halpern R; Mody RR; Fuldeore MJ; Patel PA; Mikuls TR
    Curr Med Res Opin; 2009 Jul; 25(7):1711-9. PubMed ID: 19485724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative study of the xanthine oxidase inhibitors allopurinol and oxipurinol in man.
    Chalmers RA; Krömer H; Scott JT; Watts RW
    Clin Sci; 1968 Oct; 35(2):353-62. PubMed ID: 5721238
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.